B-Cell Chronic Lymphocytic Leukemia

Showing 1 - 25 of 65

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell Trial run by the National Cancer Institute

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Anti-CD19 and anti-CD20 bicistronic CAR T- cells
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 10, 2023

Non-Hodgkin's Lymphoma, Relapsed, Chronic Lymphoid Leukemia in Relapse, Non-Hodgkin's Lymphoma Refractory Trial in United States

Completed
  • Non-Hodgkin's Lymphoma, Relapsed
  • +8 more
  • PBCAR20A
  • +2 more
  • Duarte, California
  • +4 more
Jan 4, 2023

Hypogammaglobulinemia, Bacterial Infections, B-cell Chronic Lymphocytic Leukemia Trial in Columbus, Pittsburgh (Xembify,

Recruiting
  • Hypogammaglobulinemia
  • +2 more
  • Columbus, Ohio
  • +1 more
Jan 16, 2023

B-cell Non Hodgkin Lymphoma, B-cell Chronic Lymphocytic Leukemia Trial in Milwaukee (Dose Level -1: 0.75x10^6 cells/kg

Recruiting
  • B-cell Non Hodgkin Lymphoma
  • B-cell Chronic Lymphocytic Leukemia
  • Dose Level -1: 0.75x10^6 cells/kg CAR20.19.22 cells
  • +3 more
  • Milwaukee, Wisconsin
    Medical College of Wisconsin and Froedtert Hospital
Jul 1, 2022

B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in United States (Cirmtuzumab (2-16

Recruiting
  • B-cell Chronic Lymphocytic Leukemia
  • +3 more
  • Cirmtuzumab (2-16 kg/mg) plus Ibrutinib
  • +5 more
  • Duarte, California
  • +12 more
Jun 16, 2022

B-cell Chronic Lymphocytic Leukemia Trial in Peking (Alemtuzumab)

Suspended
  • B-cell Chronic Lymphocytic Leukemia
  • Alemtuzumab
  • Peking, Beijing, China
    Peking University Cancer Hospital
Jun 15, 2022

Lymphoma, B-Cell, Lymphoma, Non-hodgkins, Chronic Lymphocytic Leukemia Trial run by the NCI (Anti-cluster of differentiation 19

Terminated
  • Lymphoma, B-Cell
  • +3 more
  • Anti-cluster of differentiation 19 (CD19)-Chimeric Antigen Receptors (CAR) and Anti-cluster of differentiation 20 (CD20)-CAR T cells
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 26, 2022

B-cell Chronic Lymphocytic Leukemia Trial in Worldwide (Lenalidomide, Placebo)

Completed
  • B-cell Chronic Lymphocytic Leukemia
  • Phoenix, Arizona
  • +240 more
Nov 24, 2021

Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Diffuse Large Cell

Active, not recruiting
  • Adult Grade III Lymphomatoid Granulomatosis
  • +71 more
  • Chicago, Illinois
  • +5 more
Oct 8, 2021

Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Waldenstrom Macroglobulinemia Trial in Milwaukee

Enrolling by invitation
  • Monoclonal Gammopathy of Undetermined Significance
  • +6 more
    • Milwaukee, Wisconsin
      Aurora Health Care
    Jul 20, 2021

    Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Burkitt Lymphoma

    Completed
    • Adult Grade III Lymphomatoid Granulomatosis
    • +88 more
    • Detroit, Michigan
      Barbara Ann Karmanos Cancer Institute
    Apr 14, 2021

    B-Cell Chronic Lymphocytic Leukemia Trial in Worldwide (Chlorambucil, Obinutuzumab, Placebo)

    Terminated
    • B-Cell Chronic Lymphocytic Leukemia
    • Haifa, Israel
    • +13 more
    Apr 6, 2021

    B-Cell Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis) Trial in Huixquilucan

    Completed
    • B-Cell Chronic Lymphocytic Leukemia
    • B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis)
    • Huixquilucan, Estado De México, Mexico
      Grupo Cooperativo de Hemopatías Malignas
    Feb 1, 2021

    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in

    Completed
    • Adult Nasal Type Extranodal NK/T-cell Lymphoma
    • +35 more
    • Akt inhibitor MK2206
    • laboratory biomarker analysis
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 14, 2020

    B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Stage 0 Chronic Lymphocytic Leukemia Trial in

    Completed
    • B-cell Chronic Lymphocytic Leukemia
    • +4 more
    • alemtuzumab
    • +9 more
    • Rochester, Minnesota
      Mayo Clinic
    Jun 11, 2020

    B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Well-differentiated Lymphocytic Lymphoma Trial in

    Completed
    • B-cell Chronic Lymphocytic Leukemia
    • +9 more
    • Stanford, California
    • +15 more
    May 14, 2020

    B-Cell Chronic Lymphocytic Leukemia Trial in Vilnius (Rituximab, Glucocorticoid)

    Completed
    • B-Cell Chronic Lymphocytic Leukemia
    • Vilnius, Lithuania
      Vilnius University Hospital Santaros Klinikos
    Dec 17, 2019

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +44 more
    • fludarabine phosphate
    • +9 more
    • Duarte, California
    • +6 more
    Sep 6, 2019

    B-Cell Chronic Lymphocytic Leukemia Trial in Worldwide (Lenalidomide, Chlorambucil)

    Completed
    • B-Cell Chronic Lymphocytic Leukemia
    • Escondido, California
    • +164 more
    Jun 14, 2019

    Hematopoietic/Lymphoid Cancer, Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia Trial

    Completed
    • Hematopoietic/Lymphoid Cancer
    • +22 more
    • CART-19
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of The University of Pennsylvania
    Jun 21, 2019

    B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma Trial in United States (Samalizumab)

    Terminated
    • B-cell Chronic Lymphocytic Leukemia
    • Multiple Myeloma
    • Tucson, Arizona
    • +3 more
    Feb 12, 2019

    B-cell Lymphoma Recurrent, B-cell Chronic Lymphocytic Leukemia Trial in Beijing, Nanjing, Tianjin (YY-20394)

    Unknown status
    • B-cell Lymphoma Recurrent
    • B-cell Chronic Lymphocytic Leukemia
    • Beijing, Beijing, China
    • +2 more
    Dec 6, 2018

    Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Follicular Trial in Argentina, United States (ASN002 Dose

    Terminated
    • Lymphoma, Large B-Cell, Diffuse
    • +20 more
    • ASN002 Dose Escalation
    • ASN002 RD
    • Tempe, Arizona
    • +13 more
    Aug 13, 2018

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

    Completed
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +117 more
    • Ann Arbor, Michigan
      University of Michigan University Hospital
    Jun 28, 2018

    B-cell Adult Acute Lymphoblastic Leukemia, B-cell Chronic Lymphocytic Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma Trial in

    Terminated
    • B-cell Adult Acute Lymphoblastic Leukemia
    • +26 more
    • 6,8-bis(benzylthio)octanoic acid
    • +3 more
    • Winston-Salem, North Carolina
      Comprehensive Cancer Center of Wake Forest University
    Jun 29, 2018